BIO Investor Forum

October 13-14, 2020・Westin St. Francis Hotel, San Francisco, CA

2019 Advisory Committee

The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions. 

Mahima Agochiya, PhD, Business Development & Program Manager, SPARK Translational Research Program, Stanford University

Janice Bourque, Managing Director, Life Sciences, Hercules Technology Growth Capital

Jason Camm, Managing Director and Chief Medical Officer, Thiel Capital LLC

Alice Chen, PhD, Vice President, Accelerator Life Science Partners

Jung Choi, Chief Business & Strategy Officer, Global Blood Therapeutics

Shelley Chu, MD, PhD, Partner, Abingworth

Rajeev Dadoo, PhD, Partner, S.R. One Limited

Gini Deshpande, PhD, Founder & Chief Executive Officer, NuMedii

Jack Florio, Partner, Strategy Consulting Practice, Deallus

Julie Gilmore, PhD, Chief Operating Officer, Lilly Research Labs, Eli Lilly and Company

Tao Huang, PhD, JD, Venture Partner, Cenova Capital

Charlotte Hubbert, PhD, Partner, Gates Foundation Venture Capital

Alexis Ji, PhD, Partner, Illumina Ventures

Margaret Kim, Executive Director, Life Sciences, JPMorgan Chase & Co.

Ravi Kiron, PhD, Head, BioPharma External Innovation, EMD Serono

Jennifer Landress, Senior Vice President and Chief Operating Officer, Biocom

Bill Martin, PhD, President and Chief Operating Officer, Blackthorn Therapeutics

Samantha Miller, MSc, MBA, Co-Founder and Chief Operating Officer/Chief Business Officer, Cadence Health

Carolyn Ng, PhD, Managing Director, Vertex Ventures HC

Peter Noymer, PhD, Former President and CEO, Kedalion Therapeutics; Independent Advisor

Stephen Ritoch, Chairman & Chief Executive Officer, Blaise Group International

John Ryan, Managing Director, Wells Fargo Strategic Capital

Andrew Setikas, Senior Vice President, Business Development and Strategy, California Life Sciences Association

Mahendra G. Shah, PhD, Managing Director, Vivo Capital

Ruchita Sinha, Senior Director of Investments, Sanofi Ventures

Komathi Stem, Founder & Chief Executive Officer, monARC Bionetworks

Samuel Wu, MD, PhD, Managing Director, Acuris Partners

Asish Xavier, PhD, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.